Evaluation of epicardial adipose tissue in patients with pulmonary hypertension by cardiac magnetic resonance imaging

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100049804

Enrollment

Unknown

Registered

2021-08-09

Start date

2021-08-09

Completion date

Unknown

Last updated

2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary hypertension

Interventions

Case series:None

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. PH patients as the experimental group. There is a clear diagnosis of right heart catheterization: mPAP>=25mmHg; 2. Aged over 18 years old; 3. Etiology: idiopathic PAH, connective tissue-related PAH, congenital heart disease PAH, chronic thromboembolic PH.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of coronary heart disease, atrial fibrillation, atrial flutter, cardiomyopathy, peripheral arterial disease, and chronic obstructive pulmonary disease. 2. Patients with pulmonary hypertension in other groups.

Design outcomes

Primary

Measure	Time frame
epicardial adipose tissue;	—

Countries

China

Contacts

Public ContactLi Jiang

Second Xiangya Hospital of Central South University

lijiangcs@csu.edu.cn+86 13975128898

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026